|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,765 KRW | 0.00% |
|
+2.92% | -18.55% |
| 2023 | ViGenCell Inc.(KOSDAQ:A308080) dropped from S&P Global BMI Index | CI |
| 2023 | ViGenCell Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
ViGenCell Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was KRW 17,393.27 million compared to KRW 11,113.88 million a year ago. Basic loss per share from continuing operations was KRW 916 compared to KRW 646 a year ago.
Diluted loss per share from continuing operations was KRW 916 compared to KRW 759 a year ago. Basic loss per share was KRW 916 compared to KRW 646 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.55% | 66.35M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
VIGENCELL INC. 
